357 related articles for article (PubMed ID: 32156457)
1. Tolerance and efficacy of dose escalation using IMRT combined with chemotherapy for unresectable esophageal carcinoma: Long-term results of 51 patients.
Modesto A; Dalmasso C; Lusque A; Vieillevigne L; Izar F; Moyal E; Carrère N; Guimbaud R; Rives M
Cancer Radiother; 2020 Apr; 24(2):88-92. PubMed ID: 32156457
[TBL] [Abstract][Full Text] [Related]
2. Intensity modulated radiotherapy (IMRT) with concurrent chemotherapy as definitive treatment of locally advanced esophageal cancer.
Roeder F; Nicolay NH; Nguyen T; Saleh-Ebrahimi L; Askoxylakis V; Bostel T; Zwicker F; Debus J; Timke C; Huber PE
Radiat Oncol; 2014 Aug; 9():191. PubMed ID: 25175056
[TBL] [Abstract][Full Text] [Related]
3. Concurrent oxaliplatin, 5-fluorouracil, and radiotherapy in the treatment of locally advanced esophageal carcinoma.
O'Connor BM; Chadha MK; Pande A; Lombardo JC; Nwogu CE; Nava HR; Yang G; Javle MM
Cancer J; 2007; 13(2):119-24. PubMed ID: 17476140
[TBL] [Abstract][Full Text] [Related]
4. Intensity-modulated radiotherapy combined with paclitaxel and platinum treatment regimens in locally advanced esophageal squamous cell carcinoma.
Chen J; Su T; Lin Y; Wang B; Li J; Pan J; Chen C
Clin Transl Oncol; 2018 Mar; 20(3):411-419. PubMed ID: 28779422
[TBL] [Abstract][Full Text] [Related]
5. Semi-radical chemoradiotherapy for 53 esophageal squamous cell carcinomas with supraclavicular lymph node metastasis in a single institutional retrospective study.
Yamashita M; Takenaka HY; Nakagawa K
Hepatogastroenterology; 2014 Oct; 61(135):1971-8. PubMed ID: 25713897
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma.
Zhu HT; Ai DS; Tang HR; Badakhshi H; Fan JH; Deng JY; Zhang JH; Chen Y; Zhang Z; Xia Y; Guo XM; Jiang GL; Zhao KL
World J Gastroenterol; 2017 Jan; 23(3):540-546. PubMed ID: 28210091
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.
Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
Radiat Oncol; 2017 Aug; 12(1):131. PubMed ID: 28810885
[TBL] [Abstract][Full Text] [Related]
8. Effect of Intensity Modulated Radiation Therapy With Concurrent Chemotherapy on Survival for Patients With Cervical Esophageal Carcinoma.
McDowell LJ; Huang SH; Xu W; Che J; Wong RKS; Brierley J; Kim J; Cummings B; Waldron J; Bayley A; Hansen A; Witterick I; Ringash J
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):186-195. PubMed ID: 28258892
[TBL] [Abstract][Full Text] [Related]
9. [Definitive or neo-adjuvant chemoradiation in esophageal carcinoma?].
Modesto A; Carrère N; Guimbaud R; Rives M; Deutsch É; Quéro L; Créhange G
Cancer Radiother; 2019 Oct; 23(6-7):716-719. PubMed ID: 31421997
[TBL] [Abstract][Full Text] [Related]
10. Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinoma.
Chakravarty T; Crane CH; Ajani JA; Mansfield PF; Briere TM; Beddar AS; Mok H; Reed VK; Krishnan S; Delclos ME; Das P
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):581-6. PubMed ID: 22137021
[TBL] [Abstract][Full Text] [Related]
11. Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus: mature results of a phase I/II trial.
Pöttgen C; Gkika E; Stahl M; Abu Jawad J; Gauler T; Kasper S; Trarbach T; Herrmann K; Lehmann N; Jöckel KH; Lax H; Stuschke M
Radiat Oncol; 2021 Mar; 16(1):59. PubMed ID: 33757534
[TBL] [Abstract][Full Text] [Related]
12. Outcomes after intensity-modulated compared with 3-dimensional conformal radiotherapy with chemotherapy for squamous cell carcinoma of the anal canal.
Agarwal MS; Hitchcock KE; Morris CG; George TJ; Mendenhall WM; Zlotecki RA
Curr Oncol; 2019 Aug; 26(4):e515-e521. PubMed ID: 31548820
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil-cisplatin regimen in oesophageal cancer.
Bascoul-Mollevi C; Gourgou S; Galais MP; Raoul JL; Bouché O; Douillard JY; Adenis A; Etienne PL; Juzyna B; Bedenne L; Conroy T
Eur J Cancer; 2017 Oct; 84():239-249. PubMed ID: 28829992
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of induction chemotherapy followed by chemoradiation using intensity-modulated radiation therapy for esophageal adenocarcinoma.
Gerber N; Ilson DH; Wu AJ; Janjigian YY; Kelsen DP; Zheng J; Zhang Z; Bains MS; Rizk N; Rusch VW; Goodman KA
Dis Esophagus; 2014 Apr; 27(3):235-41. PubMed ID: 23796070
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcome of intensity-modulated radiation therapy for locally advanced esophageal squamous cell carcinoma.
Ge X; Yang X; Lu X; Wen W; Zhen F; Ye H; Zhu H; Cao Y; Zhang S; Cheng H; Ma J; Yang B; Dai S; Guo Q; Cai J; Sun X
Tumori; 2015; 101(2):168-73. PubMed ID: 25791535
[TBL] [Abstract][Full Text] [Related]
16. Phase I Trial of Intensity-Modulated Hyperfractionated Radiotherapy Boost with Concurrent Chemotherapy Immediately Following Standard Chemoradiotherapy in Patients Primarily with Advanced Intra-thoracic/Cervical Esophageal Squamous Cell Carcinomas.
Cheng N; Liu Y; Zhao G; Xu Y; Zhang T; Chen Y; Yan G; Hu Y; Yao S; Wang Z; Wang C; Chen Z; Hu Z; Liu D; Chen T
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):340-348. PubMed ID: 31655197
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus.
Gkika E; Gauler T; Eberhardt W; Stahl M; Stuschke M; Pöttgen C
Dis Esophagus; 2014; 27(7):678-84. PubMed ID: 24147973
[TBL] [Abstract][Full Text] [Related]
18. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer.
Han K; Cummings BJ; Lindsay P; Skliarenko J; Craig T; Le LW; Brierley J; Wong R; Dinniwell R; Bayley AJ; Dawson LA; Ringash J; Krzyzanowska MK; Moore MJ; Chen EX; Easson AM; Kassam Z; Cho C; Kim J
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):587-94. PubMed ID: 25194664
[TBL] [Abstract][Full Text] [Related]
20. Quality Assurance of Dose-Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal cancer.
Boustani J; Rivin Del Campo E; Blanc J; Peiffert D; Benezery K; Pereira R; Rio E; Le Prisé E; Créhange G; Huguet F
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):329-337. PubMed ID: 31299242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
